Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluorocholine PET for the Detection of Parathyroid Adenomas
NCT04895631Phase 3Completed
- Start
- Jun 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of 18F-choline in primary hyperparathyroidism (PHPT). Primary endpoints: Proportion of participants with true-positives (sensitivity) of 18F-Fluorocholine PET using sestamibi imaging at 1 year and Proportion of participants with true-positives (sensitivity) of 18F-Fluorocholine PET using predefined threshold at 1 year. Started Jun 2021; status: completed.
02
Drugs
18F-choline
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT04895631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895631.